SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000910680-21-000065
Filing Date
2021-10-08
Accepted
2021-10-08 16:14:53
Documents
1
Group Members
THOMAS VON KOCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13gtom-10082021.htm SC 13G 44883
  Complete submission text file 0000910680-21-000065.txt   46474
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90788 | Film No.: 211315457
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27
Business Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27 46 70 514 21 94
TomEnterprise AB (Filed by) CIK: 0001887435 (see all company filings)

IRS No.: 000000000
Type: SC 13G